A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of nimotuzumab in combination
with chemotherapy and radiotherapy for the treatment of locally advanced esophageal cancer,
comparing it to that of the conventional treatment with radiation and chemotherapy.
The secondary objective of this study is to assess the health-related quality of life for the
nimotuzumab in combination with chemotherapy and radiotherapy regimen, compared to the
standard chemoradiation regimen in the treatment of inoperable locally advanced esophageal
cancer.